103 related articles for article (PubMed ID: 6114857)
21. Chiroinositol deficiency and insulin resistance. II. Acute effects of D-chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulin-resistant rhesus monkeys.
Ortmeyer HK; Huang LC; Zhang L; Hansen BC; Larner J
Endocrinology; 1993 Feb; 132(2):646-51. PubMed ID: 8425484
[TBL] [Abstract][Full Text] [Related]
22. Acacia nilotica leave extract and glyburide: comparison of fasting blood glucose, serum insulin, beta-thromboglubulin levels and platelet aggregation in streptozotocin induced diabetic rats.
Asad M; Munir TA; Afzal N
J Pak Med Assoc; 2011 Mar; 61(3):247-51. PubMed ID: 21465938
[TBL] [Abstract][Full Text] [Related]
23. GI hormonal changes in diabetes influence pancreatic cancer growth.
Fisher WE; Boros LG; O'Dorisio TM; O'Dorisio MS; Schirmer WJ
J Surg Res; 1995 Jun; 58(6):754-8. PubMed ID: 7791356
[TBL] [Abstract][Full Text] [Related]
24. Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats.
Pagliara AS; Stillings SN; Haymond MW; Hover BA; Matschinsky FM
J Clin Invest; 1975 Feb; 55(2):244-55. PubMed ID: 123928
[TBL] [Abstract][Full Text] [Related]
25. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
26. Streptozocin-induced diabetes mellitus in the pregnant ewe.
Dickinson JE; Meyer BA; Chmielowiec S; Palmer SM
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 1):1673-7. PubMed ID: 1836305
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic hormones in streptozotocin-diabetic rats.
Tomita T; Sasaki S; Doull V; Bunag R; Kimmel JR
Int J Pancreatol; 1986 Oct; 1(3-4):265-78. PubMed ID: 2890693
[TBL] [Abstract][Full Text] [Related]
28. Effects of glucose and some oral hypoglycemic agents upon the plasma glucose and immuno-reactive insulin (IRI) in normal and streptozotocin induced diabetic rat.
Kaul CL; Talwalker PK; Grewal RS
Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):139-44. PubMed ID: 708137
[TBL] [Abstract][Full Text] [Related]
29. Origin of peripheral venous hypersomatostatinemia in alloxan-diabetic dogs.
Schusdziarra V; Rouiller D; Harris V; Unger RH
Endocrinology; 1981 Oct; 109(4):1107-16. PubMed ID: 6116595
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone and somatostatin in the plasma of transiently diabetic ducks: basal variation and response to glucose.
Laurent F; Karmann H; Harvey S; Foltzer C; Mialhe P
Gen Comp Endocrinol; 1989 May; 74(2):181-9. PubMed ID: 2565851
[TBL] [Abstract][Full Text] [Related]
31. Abnormalities of pancreatic somatostatin secretion corrected by in vivo insulin treatment of streptozotocin-diabetic rats.
Trimble ER; Gerber PP; Renold AE
Diabetes; 1981 Oct; 30(10):865-7. PubMed ID: 6168508
[TBL] [Abstract][Full Text] [Related]
32. Increase of pancreatic somatostatin concentration in early phases of streptozotocin diabetes in rats.
Kazumi T; Utsumi M; Yoshino G; Terashi K; Kobayashi N; Ishihara K; Makimura H; Morita S; Baba S
Endocrinol Jpn; 1980 Feb; 27(1):23-6. PubMed ID: 6104595
[TBL] [Abstract][Full Text] [Related]
33. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
Serradas P; Bailbé D; Portha B
Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
[TBL] [Abstract][Full Text] [Related]
34. Glucose and insulin changes following a renoportal shunt in streptozotocin diabetic rats with pancreatic islet isografts under the kidney capsule.
Reece-Smith H; McShane P; Morris PJ
Diabetologia; 1982 Oct; 23(4):343-6. PubMed ID: 6814976
[TBL] [Abstract][Full Text] [Related]
35. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
[TBL] [Abstract][Full Text] [Related]
36. Increased somatostatin secretion from pancreatic islets of streptozotocin-diabetic rats in response to glucose.
Schauder P; McIntosh C; Herberg L; Arends J; Koop H; Frerichs H; Creutzfeldt W
Mol Cell Endocrinol; 1980 Dec; 20(3):243-50. PubMed ID: 6110594
[TBL] [Abstract][Full Text] [Related]
37. Insulin resistance occurs in parallel with sensory neuropathy in streptozotocin-induced diabetes in rats: differential response to early vs late insulin supplementation.
Szilvássy Z; Németh J; Kovács P; Paragh G; Sári R; Vígh L; Peitl B
Metabolism; 2012 Jun; 61(6):776-86. PubMed ID: 22154324
[TBL] [Abstract][Full Text] [Related]
38. The role of resistance and aerobic exercise training on insulin sensitivity measures in STZ-induced Type 1 diabetic rodents.
Hall KE; McDonald MW; Grisé KN; Campos OA; Noble EG; Melling CW
Metabolism; 2013 Oct; 62(10):1485-94. PubMed ID: 23810201
[TBL] [Abstract][Full Text] [Related]
39. [Effects of exogenous and endogenous somatostatin on serum insulin concentration in streptozotocin diabetic mice].
Tu YH; Zhu WY
Sheng Li Xue Bao; 1987 Jun; 39(3):275-81. PubMed ID: 2890212
[No Abstract] [Full Text] [Related]
40. Abnormal D cell secretion in alloxan-diabetes: influence by drug and aberrant metabolism.
Grill V; Efendić S
Am J Physiol; 1984 Jun; 246(6 Pt 1):E483-92. PubMed ID: 6204535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
